BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 138353)

  • 1. The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease.
    Sergysels R; Schandevyl W; Yernault JC; Hennebert A
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):163-73. PubMed ID: 138353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].
    Langaker O
    Tidsskr Nor Laegeforen; 1982 Mar; 102(9-10):558-9. PubMed ID: 6218649
    [No Abstract]   [Full Text] [Related]  

  • 4. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 5. The background to Duovent.
    Phillips VJ
    Postgrad Med J; 1984; 60 Suppl 1():13-7. PubMed ID: 6233545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):395-408. PubMed ID: 4282560
    [No Abstract]   [Full Text] [Related]  

  • 7. Duovent--is logic enough?
    Drug Ther Bull; 1985 Jan; 23(1):3-4. PubMed ID: 3155677
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
    Tang OT; Flatley M
    Postgrad Med J; 1984; 60 Suppl 1():24-7. PubMed ID: 6233547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacer.
    Woodcock A; Humberstone A; Sutton B; Law A; Lytton S; Newey M; Pike S
    Pharmatherapeutica; 1984; 4(1):32-5. PubMed ID: 6239292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a selective indication for a parasympatholytic (Atrovent) and for a beta-sympathomimetic (Berotec) in asthma and asthmatic bronchitis?
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1976; 67(3-4):130-55. PubMed ID: 138352
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of aerosols in obstructive respiratory tract diseases. Clinical-pharmacological studies using fenoterol, salbutamol, ipratropium bromide and terbutaline].
    Kaik G
    Schweiz Med Wochenschr; 1977 Dec; 107(52):1948-57. PubMed ID: 145654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease (author's transl)].
    Kaik G
    Wien Klin Wochenschr; 1975 Oct; 87(19):653-6. PubMed ID: 132015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of obstructive disease with fenoterol-ipratropiumbromid dosage aerosol (IK 6). Short and long-terms results (author's transl)].
    Ulmer WT
    Med Klin; 1979 Oct; 74(42):1548-52. PubMed ID: 161348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
    Bezel R; Brändli O; Braun P; Haegi V; Helcl J; Villiger B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):632-6. PubMed ID: 2956661
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical experience with a bronchospasmolytic aerosol combination.
    Forche G; Harnoncourt K
    Z Erkr Atmungsorgane; 1986; 166(1):47-52. PubMed ID: 2937212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Kaik G; Kaik B; Laggner A
    Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of euphylline, berotec, and atrovent on the oxygen content and acid-base balance of patients with lung diseases].
    Zamotaev IP; Kasatkin IuN; Kabakov AI; Obukhov NV
    Ter Arkh; 1982; 54(4):52-5. PubMed ID: 6213061
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination bronchodilator therapy in asthma.
    Ruffin RE; McIntyre E; Crockett AJ; Zielonka K; Alpers JH
    J Allergy Clin Immunol; 1982 Jan; 69(1 Pt 1):60-5. PubMed ID: 6459357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.